Adakki kashayam for sura peenisam(sinusitis) in children

PHASE II NON RANDOMIZED CLINICAL STUDY ON SURA PEENISAM(SINUSITIS IN CHILDREN) WITH THE EVALUATION OF SIDDHA TRIAL DRUG ADAKKI KASAYAM.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/047576

Enrollment

Registered

2022-11-23

Start date

Unknown

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J324- Chronic pansinusitis

Interventions

Intervention1: Adakki kasayam: Adakki kasayam Dosage 15-30ml twice a day Duration 14days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Nasal congestion,running nose,headache,heaviness of head,pain and tenderness over Para nasal sinuses,recurrent sneezing

Exclusion criteria

Exclusion criteria: Vasomotor rhinitis,opthalmic headache,migraine,otitis media,congenital anomalies-septal defective,epistaxis

Design outcomes

Primary

Measure	Time frame
It is assessed by reduction in clinical symptoms like nasal discharge oedema over the sinuses head ache nasal obstruction Reduction in visual analog scaleTimepoint: 14 Days	—

Secondary

Measure	Time frame
Secondary outcome is assessed by reduction in ESR and eosinophil count X ray for paranasal sinuses, It is assessed by comparing the safety parameters before and after treatment.Timepoint: 14days	—

Countries

India

Contacts

Public ContactDr K K Subramani

Government siddha medical college,chennai

malarvizhiisha@gmail.com9444487063

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026